Literature DB >> 12362417

Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy.

Victor Chu1, Jose M Otero, Orlando Lopez, Matthew F Sullivan, James P Morgan, Ivo Amende, Thomas G Hampton.   

Abstract

The mdx mouse is a model of Duchenne muscular dystrophy (DMD). As many DMD patients die of cardiac failure, we investigated whether mdx mice exhibited clinically relevant cardiac phenotypes. We applied a recently developed method for noninvasively recording electrocardiograms (ECGs) to study male mdx mice (n = 15) and control mice (n = 15). The mdx mice had significant tachycardia and decreased heart rate variability, consistent with observations in DMD patients. Heart rate was nearly 15% faster in mdx mice than control mice (P < 0.05). The rate-corrected QT interval duration and PR interval were shorter in mdx compared to control mice (P < 0.05). The muscarinic antagonist atropine significantly increased heart rate and decreased PR interval in C57 mice. In contrast, atropine significantly decreased heart rate and increased PR interval in all mdx mice. Pharmacological autonomic blockade and baroreflex sensitivity testing demonstrated an imbalance in autonomic nervous system modulation of heart rate, with decreased parasympathetic activity and increased sympathetic activity in mdx mice. Baseline ECGs and contrary responses to muscarinic blockade by atropine in mice deficient in neuronal nitric oxide synthase (nNOS) suggest that the autonomic dysfunction in mdx mice may be independent of decreased myocardial nNOS. These electrocardiographic findings in dystrophin-deficient mice may provide new bases for diagnosing, understanding, and treating DMD patients. Copyright 2002 Wiley Periodicals, Inc. Muscle Nerve 26: 513-519, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362417     DOI: 10.1002/mus.10223

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  29 in total

1.  Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma.

Authors:  William Lewis; Brian J Day; James J Kohler; Seyed H Hosseini; Sherine S L Chan; Elgin C Green; Chad P Haase; Erin S Keebaugh; Robert Long; Tomika Ludaway; Rodney Russ; Jeffrey Steltzer; Nina Tioleco; Robert Santoianni; William C Copeland
Journal:  Lab Invest       Date:  2006-02-19       Impact factor: 5.662

2.  Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy.

Authors:  Heaseung Sophia Chung; Grace E Kim; Ronald J Holewinski; Vidya Venkatraman; Guangshuo Zhu; Djahida Bedja; David A Kass; Jennifer E Van Eyk
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-29       Impact factor: 11.205

3.  Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy.

Authors:  Tamara O Thomas; Thomas M Morgan; William B Burnette; Larry W Markham
Journal:  Pediatr Cardiol       Date:  2012-03-21       Impact factor: 1.655

4.  Lengthening-contractions in isolated myocardium impact force development and worsen cardiac contractile function in the mdx mouse model of muscular dystrophy.

Authors:  Ying Xu; Dawn A Delfín; Jill A Rafael-Fortney; Paul M L Janssen
Journal:  J Appl Physiol (1985)       Date:  2010-12-02

5.  Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy.

Authors:  Eric Himelman; Mauricio A Lillo; Julie Nouet; J Patrick Gonzalez; Qingshi Zhao; Lai-Hua Xie; Hong Li; Tong Liu; Xander Ht Wehrens; Paul D Lampe; Glenn I Fishman; Natalia Shirokova; Jorge E Contreras; Diego Fraidenraich
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

6.  Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.

Authors:  Brian Bostick; Yongping Yue; Yi Lai; Chun Long; Dejia Li; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

7.  Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.

Authors:  Sergey V Ivanov; Jerrold M Ward; Lino Tessarollo; Dorothea McAreavey; Vandana Sachdev; Lameh Fananapazir; Melissa K Banks; Nicole Morris; Draginja Djurickovic; Deborah E Devor-Henneman; Ming-Hui Wei; Gregory W Alvord; Boning Gao; James A Richardson; John D Minna; Michael A Rogawski; Michael I Lerman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.

Authors:  Caroline Lewis; Harald Jockusch; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2010-05-23

9.  Development of electrocardiogram intervals during growth of FVB/N neonate mice.

Authors:  Christopher R Heier; Thomas G Hampton; Deli Wang; Christine J Didonato
Journal:  BMC Physiol       Date:  2010-08-24

10.  Cardiac electrophysiological characteristics of the mdx ( 5cv ) mouse model of Duchenne muscular dystrophy.

Authors:  Dorothy M Branco; Cordula M Wolf; Megan Sherwood; Peter E Hammer; Peter B Kang; Charles I Berul
Journal:  J Interv Card Electrophysiol       Date:  2007-10-17       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.